Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study. - Alsina M; Shah N; Jagannath S; Kaufman JL; Siegel D; Munshi NC; Rosenblatt J; Lin Y; Jakubowiak AJ; Derman BA; Li A; Mao P; et al. (Cancer immunology research, 2026)